Drug
High Dose Budesonide Rectal Foam
High Dose Budesonide Rectal Foam: highest development phase Post-Market, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| High dose budesonide rectal foam NCT05976802 | Post-Market | Ulcerative Colitis |
Latest
No recent events.
Follow High Dose Budesonide Rectal Foam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.